Director, Disease Area Strategy Lead - General Medicine

About the role

Amgen's Disease Area Strategy Lead (DASL) function shapes where the company invests and turns scientific innovation into medicines with value for patients. The Director, Disease Area Strategy Lead - General Medicine helps shape the future of the General Medicine portfolio by combining scientific, clinical, patient, competitive and commercial perspectives into therapeutic area, portfolio and early asset decisions. The role sits at the intersection of R&D, commercial and therapeutic area strategy, working closely with the Executive Director DASL and cross-functional leaders.

Key responsibilities

• Lead the ongoing development of the General Medicine (Cardiovascular Disease and Bone Health) therapeutic area strategy, translating its ambitions into disease and franchise priorities, portfolio implications and investment priorities.
• Assess where Amgen has a differentiated right to win, where opportunities warrant investment and where to remain selective, keeping asset and program decisions aligned with broader strategy.
• Serve as the commercial strategic lead for early pipeline projects, defining patient population, unmet need, differentiation requirements, product profile and evidence needs.
• Lead cross-functional teams in creating target product profiles and development strategies, and lead New Product Planning and early commercial assessments (market, competitive, patient segmentation, positioning, forecasting).
• Drive opportunity assessments (forecasts, eNPVs, competitive landscapes) across development stages to inform indication prioritization and sequencing.
• Partner with Research, Development, Medical, Competitive Intelligence, Business Analytics and Insights to turn complex questions into clear recommendations.

Required profile

• Basic: doctorate with 4 years of marketing and/or commercial experience, or master's with 7 years, or bachelor's with 9 years.
• Preferred: advanced degree such as an MBA, PhD, PharmD, MD or MPH.
• Preferred: biopharma or life sciences strategy consulting experience, and experience in New Product Planning, pipeline commercial strategy, portfolio strategy, forecasting, market research and analytics.
• Preferred: experience evaluating early-stage assets and therapeutic area experience in cardiovascular disease or bone health.

Required skills

• Strong scientific and clinical learning agility, able to engage with scientific and clinical experts.
• Strong qualitative and quantitative strategic judgment, able to structure ambiguous problems and recommend despite uncertainty.
• Ability to lead cross-functional teams and drive decisions without formal authority.